Sort
82,697 grants matching “vaccine development”
Immunotherapeutics vs Ebola Sudan: Development, Structural & Functional Analysis
$728,213Erica Ollmann Saphire · Scripps Research Institute, The · U01 · FY2008 · AI
AMPATH-Oncology Institute: HPV and Cervical Cancer in Kenyan Women with HIV/AIDS
$728,206Patrick J Loehrer · Indiana University Indianapolis · U54 · FY2014 · CA
Molecularly Engineered Lectins for Intranasal Prophylaxis and Treatment of Coronaviruses
$728,193David Michael Markovitz · University Of Michigan At Ann Arbor · R01 · FY2023 · AI
Novel Interventions Against HPV-associated Neoplasia
$728,157Paul F Lambert · University Of Wisconsin-Madison · U01 · FY2012 · CA
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
$728,153Scott C Weaver · University Of Texas Med Br Galveston · R24 · FY2020 · AI
Structural characterization of native HBV capsids and virions from human cells
$728,019Che-Yen Wang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · AI
National Surveillance for Emerging Adenovirus Infections
$728,003University Of Iowa · R01 · FY2005 · AI
Molecular Studies on HIV Envelope for Vaccine Design
$727,932Dennis R. Burton · Maxygen, Inc. · P01 · FY2006 · AI
Research Resource Technical Development Component
$727,845Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2008 · AI
Childhood infection and prevention of obesity
$727,804Julie Parsonnet · Stanford University · R01 · FY2010 · HD
Lead Optimization of DHODH Inhibitors for Malaria
$727,804Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2019 · AI
PREVALENCE AND DETERMINANTS OF ORAL HPV INFECTION IN THE US POPULATION
$727,791Maura L Gillison · Ohio State University · R01 · FY2013 · DE
IgM in the regulation of TB immunity
$727,759John R. Chan · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Baltimore Pediatric AIDS Clinical Trials Group
$727,739Johns Hopkins University · U01 · FY2002 · AI
Extent and Significance of Bacterial DNA Integrations in the Human Cancer Genome
$727,738Julie Dunning Hotopp · University Of Maryland Baltimore · R01 · FY2020 · CA
An Orally Delivered Booster Vaccine Candidate for Hepatitis B
$727,729John A. Howard · Applied Biotechnology Institute · R44 · FY2014 · AI
Pathogenomics of Chlamydial Infection
$727,706Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Chlamydial Immunity and Vaccine Development
$727,706Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Developing a Multi-epitope Pan-Coronavirus Vaccine
$727,670Lbachir Benmohamed · University Of California-Irvine · R01 · FY2024 · AI
Animal Models Core
$727,666Barton F Haynes · Duke University · U19 · FY2019 · AI
Development of New Bivalent Cross-Protective Arenaviral Vaccines
$727,652Igor S. Lukashevich · University Of Louisville · R01 · FY2015 · AI
Development of New Bivalent Cross-Protective Arenaviral Vaccines
$727,652Igor S. Lukashevich · University Of Louisville · R01 · FY2014 · AI
Assessing Cervical Cancer Healthcare Inequities in Diverse Populations: The ACHIEVE Study
$727,581Adana A. M. Llanos · Columbia University Health Sciences · R01 · FY2023 · MD
Epitope dynamics and functional analysis of viral envelope glycoprotein by cryo-electron tomography and single particle cryo-EM
$727,531Mario Borgnia · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection
$727,487M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2022 · AI